The 33% denial rate breaks down as follows: 18% denied for insufficient documentation (fixable on appeal), 9% denied for not meeting clinical criteria (A1C too low, BMI too low), and 6% denied for administrative reasons (prescriber not in network, quantity exceeds limits)
It works by affecting the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine, which are involved in regulating mood and appetite
Around 86% of participants in the semaglutide group reported an adverse event, compared to about 80% in the placebo group
it is used here only as a general analytical-science reference and does not automatically establish mandatory release specifications for an RUO research reagent
The average body mass index when they enrolled in the study was 37 kg/m 2 , which is considered obesity
For patients, the message is mixed but useful